Septerna (SEPN) Cash from Financing Activities (2024 - 2026)

Septerna's (SEPN) quarterly Cash from Financing Activities came in at $333000.0 in Q1 2026, up 404.55% year-on-year from $66000.0 in Q1 2025, and down 67.38% quarter-over-quarter from $1.0 million in Q4 2025.

Septerna (SEPN) Cash from Financing Activities (2024 - 2026) Analysis & Trends

Septerna's Cash from Financing Activities history runs 3 years deep, the most recent figure standing at $333000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 404.55% year-over-year to $333000.0 in Q1 2026; TTM through Mar 2026 was $2.0 million, a 99.35% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 99.55% from the prior year.
  • Cash from Financing Activities retreated to $333000.0 in Q1 2026 per SEPN's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $304.2 million in Q4 2024 and bottomed at -$1.3 million in Q3 2024.
  • The 3-year median for Cash from Financing Activities is $333000.0 (2026), against an average of $43.6 million.
  • Across the five-year window, Cash from Financing Activities sank 99.66% in 2025 and jumped 404.55% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $304.2 million in 2024, then sank by 99.66% to $1.0 million in 2025, then sank by 67.38% to $333000.0 in 2026.
  • Per Business Quant, the three latest SEPN Cash from Financing Activities figures stand at $333000.0 (Q1 2026), $1.0 million (Q4 2025), and $263000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Septerna 1.50 Bn 1.50 Bn - 333,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 333,000.00
Mar 31, 2026 333,000.00
Dec 31, 2025 1.02 Mn
Dec 31, 2025 1.02 Mn
Sep 30, 2025 263,000.00
Sep 30, 2025 263,000.00
Jun 30, 2025 339,000.00
Jun 30, 2025 339,000.00
Mar 31, 2025 66,000.00
Mar 31, 2025 66,000.00
Dec 31, 2024 304.15 Mn
Dec 31, 2024 304.15 Mn
Sep 30, 2024 -1.32 Mn
Sep 30, 2024 -1.32 Mn